2016
DOI: 10.1016/j.clnesp.2016.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Overweight postmenopausal women with different plasma estradiol concentrations present with a similar pattern of energy expenditure and substrate oxidation rate before and after a fatty meal challenge

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…In general, these studies support the idea that menopause per se is associated with increasing abdominal obesity and that visceral fat accumulation may, in part, be secondary to an acceleration of aging-related decline in fat oxidation and metabolic energy expenditure [ 81 ]. While these changes parallel those observed in OVX rodents [ 168 ], a causal relationship between declining ovarian estradiol in menopause and altered body composition and energy balance has been difficult to confirm [ 169 , 170 ]. Some randomized controlled studies have demonstrated that both oral and transdermal estradiol therapy in postmenopausal women are associated with a reduction in central adiposity and an increase in lean body mass [ 171 , 172 ], as well as reductions in insulin resistance and fasting glucose, new-onset type 2 diabetes, blood lipids, blood pressure, adhesion molecules, and procoagulant factors [ 173 ].…”
Section: Discussionmentioning
confidence: 99%
“…In general, these studies support the idea that menopause per se is associated with increasing abdominal obesity and that visceral fat accumulation may, in part, be secondary to an acceleration of aging-related decline in fat oxidation and metabolic energy expenditure [ 81 ]. While these changes parallel those observed in OVX rodents [ 168 ], a causal relationship between declining ovarian estradiol in menopause and altered body composition and energy balance has been difficult to confirm [ 169 , 170 ]. Some randomized controlled studies have demonstrated that both oral and transdermal estradiol therapy in postmenopausal women are associated with a reduction in central adiposity and an increase in lean body mass [ 171 , 172 ], as well as reductions in insulin resistance and fasting glucose, new-onset type 2 diabetes, blood lipids, blood pressure, adhesion molecules, and procoagulant factors [ 173 ].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore unsurprisingly, we did not observe associations between sex hormone levels and RFO. Previous studies also questioned the relationship between E2 levels and RFO in premenopausal [41] and postmenopausal women [42].…”
Section: Sex Hormone Profile and Resting Fat Oxidationmentioning
confidence: 99%